PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

Market Cap	9.35B +50.7%
Revenue (ttm)	1.98B +26.8%
Net Income	201.14M +14.9%
EPS	1.00 +14.5%
Shares Out	232.97M
PE Ratio	40.19
Forward PE	43.41
Dividend	0.28 (0.70%)
Ex-Dividend Date	May 30, 2025

Volume	5,477,970
Average Volume	14,960,187
Open	41.73
Previous Close	40.15
Day's Range	40.10 - 41.73
52-Week Range	27.07 - 53.54
Beta	0.71
RSI	47.21
Earnings Date	Apr 22, 2026

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 2,455
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300725

Financial Performance

In 2024, SHE:300725's revenue was 1.69 billion, a decrease of -2.12% compared to the previous year's 1.73 billion. Earnings were 219.54 million, an increase of 11.24%.